Robbins arroyo llp is investigating the officers and directors of insmed, inc. (insm) on behalf of shareholders

San diego & bridgewater, n.j.--(business wire)--shareholder rights law firm robbins arroyo llp is investigating whether certain officers and directors of insmed, inc. (nasdaqgs: insm) breached their fiduciary duties to shareholders by misleading investors about the company's lead product candidate. insmed, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapies for patients with serious lung diseases. view this press release on the law firm's shareholder rights blog: www.robbinsarroyo.com/shareholders-rights-blog/insmed-inc-nov-2016 insmed shareholders have legal options concerned shareholders who would like more information about their rights and potential remedies can contact attorney darnell r. donahue at (800) 350-6003, ddonahue@robbinsarroyo.com, or via the shareholder information form on the firm's website. robbins arroyo llp is a nationally recognized leader in shareholder rights law. the firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. attorney advertising. past results do not guarantee a similar outcome.
INSM Ratings Summary
INSM Quant Ranking